Pharma Journalist -

Novan announced that the Company has established a strategic alliance with Orion Corporation, a Finnish full-scale pharmaceutical company with broad experience in manufacturing. The…
Read More...

MeiraGTx Holdings Plc announced that it has entered into a research collaboration and evaluation agreement with Janssen Pharmaceuticals, Inc. (Janssen), one of the Janssen…
Read More...

AstraZeneca and Merck announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation (ODD) for LYNPARZA for the treatment of pancreatic cancer. LYNPARZA is…
Read More...

Aclaris Therapeutics announced it has entered into a definitive asset purchase agreement with Allergan Sales, LLC to acquire worldwide rights to RHOFADE (oxymetazoline hydrochloride)…
Read More...

HiFiBiO Therapeutics announced the acquisition of H-Immune Therapeutics, an early-stage biotechnology company engaged in the discovery and development of novel immuno-oncology…
Read More...

The National Institute of General Medical Sciences of NIH has awarded a Small Business Innovative Research grant to Allele Biotechnology and Pharmaceuticals to develop new single-domain…
Read More...

MaaT Pharma announced the dosing of the first patient in a Phase 2 clinical trial of its lead microbiome restoration candidate, MaaT013, in patients with steroid-resistant acute…
Read More...

Telix Pharmaceuticals announced that it has expanded its partnership with Advanced Nuclear Medicine Ingredients SA (“ANMI”) for the 68Ga-HBED-CC-PSMA-11 (68Ga-PSMA) cold kit. The …
Read More...

Sandoz announced a global resolution of all intellectual property (IP) related litigation with AbbVie concerning the proposed Sandoz biosimilar Hyrimoz (adalimumab) for reference…
Read More...

Almac Group announced the completion of an investment in its Durham, North Carolina Clinical Services’ and Diagnostic Services’ capabilities with the opening of a 24,000 sq. ft.…
Read More...